195 related articles for article (PubMed ID: 18640146)
21. Antinociceptive effects of morphine, fentanyl, tramadol and their combination, in morphine-tolerant mice.
Romero A; Miranda HF; Puig MM
Pharmacol Biochem Behav; 2010 Dec; 97(2):363-9. PubMed ID: 20843476
[TBL] [Abstract][Full Text] [Related]
22. Associative and non-associative fentanyl tolerance in the rat: evaluation of cross tolerance with mu-and kappa-specific opioids.
Carter BL; Tiffany ST; Conklin CA
Psychopharmacology (Berl); 2000 Mar; 148(4):384-92. PubMed ID: 10928311
[TBL] [Abstract][Full Text] [Related]
23. Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo.
Yoburn BC; Purohit V; Patel K; Zhang Q
Eur J Pharmacol; 2004 Sep; 498(1-3):87-96. PubMed ID: 15363980
[TBL] [Abstract][Full Text] [Related]
24. Influence of continuous levels of fentanyl in rats on the mu-opioid receptor in the central nervous system.
Albrecht E; Heinrich N; Lorenz D; Baeger I; Samovilova N; Fechner K; Berger H
Pharmacol Biochem Behav; 1997 Sep; 58(1):189-94. PubMed ID: 9264090
[TBL] [Abstract][Full Text] [Related]
25. Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice.
Szentirmay AK; Király KP; Lenkey N; Lackó E; Al-Khrasani M; Friedmann T; Timár J; Gyarmati S; Tóth G; Fürst S; Riba P
Brain Res Bull; 2013 Jan; 90():66-71. PubMed ID: 22995282
[TBL] [Abstract][Full Text] [Related]
26. Methadone Reverses Analgesic Tolerance Induced by Morphine Pretreatment.
Posa L; Accarie A; Noble F; Marie N
Int J Neuropsychopharmacol; 2016 Jul; 19(7):. PubMed ID: 26390873
[TBL] [Abstract][Full Text] [Related]
27. Sensitization and tolerance to the discriminative stimulus effects of mu-opioid agonists.
Paronis CA; Holtzman SG
Psychopharmacology (Berl); 1994 May; 114(4):601-10. PubMed ID: 7855222
[TBL] [Abstract][Full Text] [Related]
28. The behavioral effects of a mixed efficacy antinociceptive peptide, VRP26, following chronic administration in mice.
Anand JP; Boyer BT; Mosberg HI; Jutkiewicz EM
Psychopharmacology (Berl); 2016 Jul; 233(13):2479-87. PubMed ID: 27117141
[TBL] [Abstract][Full Text] [Related]
29. Synergistic antinociceptive actions and tolerance development produced by morphine-fentanyl coadministration: correlation with μ-opioid receptor internalization.
Silva-Moreno A; Gonzalez-Espinosa C; León-Olea M; Cruz SL
Eur J Pharmacol; 2012 Jan; 674(2-3):239-47. PubMed ID: 22079772
[TBL] [Abstract][Full Text] [Related]
30. Differences in tolerance to anti-hyperalgesic effects between chronic treatment with morphine and fentanyl under a state of pain.
Imai S; Narita M; Hashimoto S; Nakamura A; Miyoshi K; Nozaki H; Hareyama N; Takagi T; Suzuki M; Narita M; Suzuki T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Nov; 26(5-6):183-92. PubMed ID: 17240843
[TBL] [Abstract][Full Text] [Related]
31. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
Smith PA; Selley DE; Sim-Selley LJ; Welch SP
Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035
[TBL] [Abstract][Full Text] [Related]
32. Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids.
Zhang L; Walker EA; Sutherland J; Young AM
Psychopharmacology (Berl); 2000 Feb; 148(2):136-45. PubMed ID: 10663428
[TBL] [Abstract][Full Text] [Related]
33. Tolerance and cross-tolerance to morphine-like stimulus effects of mu opioids in rats.
Walker EA; Richardson TM; Young AM
Psychopharmacology (Berl); 1997 Sep; 133(1):17-28. PubMed ID: 9335076
[TBL] [Abstract][Full Text] [Related]
34. Resistance to morphine analgesic tolerance in rats with deleted transient receptor potential vanilloid type 1-expressing sensory neurons.
Chen SR; Prunean A; Pan HM; Welker KL; Pan HL
Neuroscience; 2007 Mar; 145(2):676-85. PubMed ID: 17239544
[TBL] [Abstract][Full Text] [Related]
35. The effect of nimodipine on opioid antagonist-induced upregulation and supersensitivity.
Lee SC; Yoburn BC
Pharmacol Biochem Behav; 2000 Jun; 66(2):347-51. PubMed ID: 10880689
[TBL] [Abstract][Full Text] [Related]
36. Mu opioid analgesia and analgesic tolerance in two mouse strains: C57BL/6 and 129/SvJ.
Varnado-Rhodes Y; Gunther J; Terman GW; Chavkin C
Proc West Pharmacol Soc; 2000; 43():15-7. PubMed ID: 11056944
[No Abstract] [Full Text] [Related]
37. The effect of ethanol drinking on opioid analgesia and receptors in mice.
Shah S; Duttaroy A; Sehba F; Chen B; Philippe J; Monderson T; Lau-Cam C; Carroll J; Yoburn BC
Alcohol; 1997; 14(4):361-6. PubMed ID: 9209551
[TBL] [Abstract][Full Text] [Related]
38. Spinal Opioid Tolerance Depends upon Platelet-Derived Growth Factor Receptor-
Puig S; Barker KE; Szott SR; Kann PT; Morris JS; Gutstein HB
Mol Pharmacol; 2020 Oct; 98(4):487-496. PubMed ID: 32723769
[TBL] [Abstract][Full Text] [Related]
39. Fentanyl and its analogs desensitize the cloned mu opioid receptor.
Bot G; Blake AD; Li S; Reisine T
J Pharmacol Exp Ther; 1998 Jun; 285(3):1207-18. PubMed ID: 9618424
[TBL] [Abstract][Full Text] [Related]
40. Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine.
Adams JU; Paronis CA; Holtzman SG
J Pharmacol Exp Ther; 1990 Dec; 255(3):1027-32. PubMed ID: 2175793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
